PT  - JOURNAL ARTICLE
AU  - Namita Kumar
AU  - David J Armstrong
TI  - Cardiovascular disease – the silent killer in rheumatoid arthritis
AID  - 10.7861/clinmedicine.8-4-384
DP  - 2008 Aug 01
TA  - Clinical Medicine
PG  - 384--387
VI  - 8
IP  - 4
4099  - http://www.rcpjournals.org/content/8/4/384.short
4100  - http://www.rcpjournals.org/content/8/4/384.full
SO  - Clin Med2008 Aug 01; 8
AB  - Rheumatoid arthritis (RA) is a multi-system disease with high rates of morbidity and mortality. In recent years, there has been increasing focus on the growing rates of cardiovascular disease (CVD) in RA, over and above expected levels allowing for ‘traditional’ risk factors. In this paper the impact of CVD in RA, the relative contributions of traditional risk factors and novel risk factors (including homocysteine, oxidised low-density lipoprotein, high-sensitivity C-reactive protein and leptin), and the need to address cardiovascular risk in the fight against premature death from coronary artery and stroke disease in RA are discussed.